Trial Profile
Clinical Biomarkers of Disease Activity and Treatment Responses in Patients With CNS Sarcoidosis Treated With H.P. Acthar Gel
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Sarcoidosis
- Focus Therapeutic Use
- 15 Aug 2019 Status changed from recruiting to completed.
- 29 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 May 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.